Tesla
TSLA
Meta Platforms
META
Coinbase
COIN
Microsoft
MSFT
Alphabet-A
GOOGL
US Stock MarketDetailed Quotes
DNA Ginkgo Bioworks
- 9.610
- +0.910+10.46%
Close Dec 2 16:00 ET
- 9.610
- 0.0000.00%
Pre 04:01 ET
552.37MMarket Cap-745P/E (TTM)
9.735High8.690Low1.50MVolume8.800Open8.700Pre Close13.89MTurnover3.83%Turnover RatioLossP/E (Static)57.48MShares75.20052wk High0.69P/B376.82MFloat Cap5.26052wk Low--Dividend TTM39.21MShs Float634.560Historical High--Div YieldTTM12.01%Amplitude5.260Historical Low9.249Avg Price1Lot Size
Ginkgo Bioworks Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 59.12%88.2M | -30.24%56.21M | -52.98%37.94M | -47.36%251.46M | -64.64%34.76M | -16.52%55.43M | -44.29%80.57M | -52.08%80.7M | 52.21%477.71M | -33.81%98.29M |
| Operating revenue | 59.12%88.2M | -30.24%56.21M | -52.98%37.94M | -47.36%251.46M | -64.64%34.76M | -16.52%55.43M | -44.29%80.57M | -52.08%80.7M | 52.21%477.71M | -33.81%98.29M |
| Cost of revenue | 73.38%12M | -24.18%13.72M | -58.87%9.2M | -73.55%54.01M | -78.12%6.61M | -71.92%6.92M | -71.69%18.1M | -73.81%22.38M | 57.46%204.22M | -54.61%30.22M |
| Gross profit | 57.09%76.2M | -31.99%42.49M | -50.72%28.74M | -27.80%197.45M | -58.65%28.14M | 16.20%48.51M | -22.59%62.47M | -29.70%58.33M | 48.52%273.49M | -16.91%68.07M |
| Operating expense | -45.83%129.3M | -18.70%200.51M | -24.57%206.74M | -61.10%965.65M | -31.00%206.26M | -65.74%238.69M | -66.15%246.62M | -63.86%274.07M | 23.34%2.48B | -83.08%298.93M |
| Selling and administrative expenses | -36.25%52.29M | -35.23%66.29M | -36.92%70.29M | -73.07%385.03M | -26.49%89.22M | -81.15%82.03M | -76.66%102.34M | -74.37%111.43M | 65.69%1.43B | -84.47%121.38M |
| -General and administrative expense | -36.25%52.29M | -35.23%66.29M | -36.92%70.29M | -73.07%385.03M | -26.49%89.22M | -81.15%82.03M | -76.66%102.34M | -74.37%111.43M | 65.69%1.43B | -84.47%121.38M |
| Research and development costs | -50.85%77.01M | -6.97%134.22M | -16.10%136.46M | -44.84%580.62M | -34.08%117.04M | -40.08%156.66M | -50.26%144.28M | -49.74%162.64M | -8.44%1.05B | -81.98%177.55M |
| Operating profit | 72.08%-53.1M | 14.19%-158.02M | 17.49%-178M | 65.22%-768.2M | 22.85%-178.12M | 70.96%-190.18M | 71.57%-184.15M | 68.06%-215.75M | -20.81%-2.21B | 86.30%-230.86M |
| Net non-operating interest income expense | -38.41%9.25M | -28.13%10.31M | -19.48%11.71M | 183.41%57.12M | 16.54%13.21M | 135.42%15.02M | 533.79%14.35M | 8,117.51%14.55M | 1,412.24%20.16M | 20,709.09%11.34M |
| Non-operating interest income | -38.41%9.25M | -28.13%10.31M | -19.48%11.71M | 182.39%57.22M | --13.3M | --15.02M | 533.79%14.35M | 8,117.51%14.55M | 2,320.79%20.26M | ---- |
| Non-operating interest expense | ---- | ---- | ---- | -12.26%93K | ---- | ---- | ---- | ---- | -95.53%106K | ---- |
| Other net income (expense) | 89.88%-12.93M | -1,910.53%-69.28M | 111.15%411K | -369.85%-181.87M | -248.31%-46.99M | -491.41%-127.75M | 86.27%-3.45M | -104.47%-3.69M | 930.11%67.4M | -59.95%31.68M |
| Gain on sale of security | 86.81%-4.54M | 45.59%-3.59M | 68.95%-1.6M | -169.32%-49.66M | -122.28%-3.46M | -142.43%-34.43M | 56.46%-6.6M | -106.04%-5.17M | 52.18%71.64M | -75.19%15.52M |
| Earnings from equity interest | --0 | --0 | --0 | 93.98%-2.64M | -111.19%-1.12M | --0 | 99.34%-67K | 93.06%-1.45M | 43.38%-43.76M | 314.52%10M |
| Special income (charges) | 89.65%-9.96M | ---64.92M | ---- | -534.98%-138.71M | ---42.5M | -701.73%-96.21M | --0 | ---- | 33.84%31.89M | --0 |
| -Less：Restructuring and merger&acquisition | --2.95M | --17.07M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Less:Impairment of capital assets | --0 | --47.86M | ---- | --96.21M | --0 | --96.21M | --0 | ---- | --0 | --0 |
| -Gain on sale of business | ---7.01M | ---- | ---- | -233.28%-42.5M | ---42.5M | --0 | ---- | ---- | --31.89M | --0 |
| Other non- operating income (expenses) | -45.66%1.57M | -123.76%-766K | -31.18%2.02M | 19.70%9.14M | -98.49%93K | 527.96%2.89M | 1,301.74%3.22M | 52.58%2.93M | 540.51%7.63M | 337.33%6.16M |
| Income before tax | 81.26%-56.78M | -25.25%-216.99M | 19.04%-165.88M | 57.91%-892.94M | -12.80%-211.89M | 54.80%-302.91M | 74.17%-173.25M | 65.44%-204.89M | -15.41%-2.12B | 88.30%-187.85M |
| Income tax | -1,604.55%-375K | 183.58%190K | -62.20%31K | 99.53%-71K | 98.66%-198K | 21.43%-22K | 248.89%67K | 144.57%82K | -915.34%-15.03M | -2,062.52%-14.77M |
| Net income | 81.38%-56.4M | -25.31%-217.18M | 19.06%-165.91M | 57.61%-892.87M | -22.31%-211.69M | 54.80%-302.89M | 74.15%-173.32M | 65.41%-204.97M | -14.69%-2.11B | 89.22%-173.08M |
| Net income continuous Operations | 81.38%-56.4M | -25.31%-217.18M | 19.06%-165.91M | 57.61%-892.87M | -22.31%-211.69M | 54.80%-302.89M | 74.15%-173.32M | 65.41%-204.97M | -14.69%-2.11B | 89.22%-173.08M |
| Minority interest income | 0 | 78.12%-1.44M | 155.08%2.39M | |||||||
| Net income attributable to the parent company | 81.38%-56.4M | -25.31%-217.18M | 19.06%-165.91M | 57.58%-892.87M | -20.65%-211.69M | 54.80%-302.89M | 74.09%-173.32M | 65.29%-204.97M | -15.02%-2.1B | 89.04%-175.47M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 29K | 184K | -24.06%464K | 0 | 0 | 0 | 0 | 611K | -94.64%3.14M | |
| Net income attributable to common stockholders | 81.37%-56.43M | -25.42%-217.37M | 19.07%-166.38M | 57.65%-892.87M | -18.52%-211.69M | 54.80%-302.89M | 74.09%-173.32M | 65.19%-205.58M | -11.62%-2.11B | 89.24%-178.61M |
| Basic earnings per share | 82.61%-1.08 | -22.22%-4.4 | 27.27%-3.2 | 63.20%-18.4 | -19.72%-4.31 | 62.13%-6.21 | 78.05%-3.6 | 70.27%-4.4 | 7.41%-50 | 91.43%-3.6 |
| Diluted earnings per share | 82.61%-1.08 | -22.22%-4.4 | 27.27%-3.2 | 63.20%-18.4 | -7.75%-4.31 | 62.13%-6.21 | 78.05%-3.6 | 70.27%-4.4 | 10.07%-50 | 90.91%-4 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.